Legal status · United States
Is Leptin legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Leptin is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 7 human studies are cited on its profile.
Leptin in the United States at a glance
| Classification | FDA-approved, prescription only |
|---|---|
| Note | Myalept, generalised lipodystrophy only, dispensed through the MYALEPT REMS programme. Not indicated for obesity, partial lipodystrophy, HIV-related lipodystrophy or liver disease. |
| FDA approval status | Metreleptin (Myalept) FDA-approved 24 February 2014 (BLA 125390, Chiesi) as an adjunct to diet for complications of leptin deficiency in congenital or acquired generalised lipodystrophy; Drugs@FDA marketing status Prescription on 11 September 2026. Boxed warning for neutralising anti-metreleptin antibodies and T-cell lymphoma; REMS restricted. Not indicated for obesity. Native leptin is not a product. |
| Human studies cited | 7 of 10 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Leptin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Leptin for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Leptin is
The fat-derived hormone that tells the brain how much energy is stored. Replacing it transforms the rare people who lack it; in common obesity a 127-person randomised trial in 1999 found small dose-dependent weight loss and no drug came of it. Metreleptin is approved for generalised lipodystrophy with a boxed warning.
Leptin is secreted by white fat cells roughly in proportion to fat mass and acts on the hypothalamus through the leptin receptor. It is better understood as a starvation signal than a satiety signal: falling leptin triggers a strong defence of body weight, while raising leptin in someone who already has plenty does very little.
Mechanism: Established in humans through deficiency and replacement: leptin binds the long form of the leptin receptor on hypothalamic neurons, signalling through JAK2 and STAT3, inhibiting the orexigenic NPY and AgRP neurons and activating POMC neurons upstream of the melanocortin-4 receptor. Absence of leptin in humans causes hyperphagia, severe early obesity, hypogonadotropic hypogonadism, altered thyroid function and impaired T cell immunity, all of which reverse with replacement.
Regulatory history: Metreleptin (Myalept) FDA-approved 24 February 2014 (BLA 125390, Chiesi) as an adjunct to diet for complications of leptin deficiency in congenital or acquired generalised lipodystrophy; Drugs@FDA marketing status Prescription on 11 September 2026. Boxed warning for neutralising anti-metreleptin antibodies and T-cell lymphoma; REMS restricted. Not indicated for obesity. Native leptin is not a product.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Leptin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Leptin in other countries
Frequently asked questions
Is Leptin legal in the United States?
Yes. Leptin is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 7 human studies are cited on its profile. Note: Myalept, generalised lipodystrophy only, dispensed through the MYALEPT REMS programme. Not indicated for obesity, partial lipodystrophy, HIV-related lipodystrophy or liver disease.
Can I buy Leptin in the United States?
Only with a prescription. Leptin is classified as "FDA-approved, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Myalept, generalised lipodystrophy only, dispensed through the MYALEPT REMS programme. Not indicated for obesity, partial lipodystrophy, HIV-related lipodystrophy or liver disease.
Is Leptin FDA approved?
Yes. FDA status: Metreleptin (Myalept) FDA-approved 24 February 2014 (BLA 125390, Chiesi) as an adjunct to diet for complications of leptin deficiency in congenital or acquired generalised lipodystrophy; Drugs@FDA marketing status Prescription on 11 September 2026. Boxed warning for neutralising anti-metreleptin antibodies and T-cell lymphoma; REMS restricted. Not indicated for obesity. Native leptin is not a product.. Current US classification: "FDA-approved, prescription only". On the evidence, 7 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Leptin live on its compound profile.
Leptin profileThis page is general information about the regulatory status of Leptin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.